ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 326,31
-0,89%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bioventus Inc (BVS)

  7. Bioventus Inc (BVS) Actualités

BVS Bioventus Inc

3,97
0,01 (0,25%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Bioventus Inc BVS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,25% 3,97 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,04 3,94 4,1199 3,97 3,96
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202413:30GLOBEBioventus to Report First Quarter of Fiscal Year 2024..
12/3/202412:30GLOBEBioventus Announces Fourth Quarter and Full Year 2023..
04/3/202414:00GLOBEBioventus to Report Fourth Quarter of Fiscal Year 2023..
06/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202422:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202414:27EDGAR2Form 8-K - Current report
18/1/202422:15GLOBEBioventus Enters into an Amendment with its Credit Agreement..
12/1/202423:10EDGAR2Form 8-K - Current report
12/1/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/1/202422:15GLOBEBioventus Announces Inducement Equity to President and Chief..
09/1/202414:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202314:00EDGAR2Form 8-K - Current report
19/12/202322:30GLOBEBioventus Names Robert Claypoole as President and Chief..
06/12/202314:00GLOBEBioventus Agrees to Nationwide Contract with Aetna™ Medicare..
07/11/202313:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:35EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEBioventus Reports Third Quarter Financial Results; Raises..
31/10/202312:00GLOBEBioventus to Report Third Quarter of Fiscal Year 2023..
20/9/202303:52GLOBEBioventus to Present at the Cantor Global Healthcare..
06/9/202322:30GLOBEBioventus to Present at the Morgan Stanley 21st Annual..
08/8/202314:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:02EDGAR2Form 8-K - Current report
08/8/202313:30GLOBEBioventus Reports Second Quarter Financial Results;..
04/8/202314:30GLOBEBioventus to Present at the Canaccord Genuity 43rd Annual..
01/8/202323:35GLOBEBioventus to Report Second Quarter of Fiscal Year 2023..
23/5/202313:30GLOBEBioventus Completes Divestiture of its Wound Business
16/5/202322:15GLOBEBioventus Reports First Quarter Financial Results
15/5/202323:33GLOBEBioventus Reschedules Reporting of First Quarter Fiscal Year..
11/5/202313:00GLOBEBioventus Reschedules Earnings Call to May 16, 2023; Files..
10/5/202315:00GLOBEBioventus Announces Divestiture of its Wound Business

Dernières Valeurs Consultées

NASDAQ
BVS
Bioventus
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés